Psychosomatic Approach to Clinical Practice

  • Eliana Tossani
  • Giovanni Andrea FavaEmail author


Stemming from Lipowski’s original definition [1] and subsequent developments [2–4], psychosomatic medicine may be defined as a comprehensive and interdisciplinary framework for:


Irritable Bowel Syndrome Medical Disease Allostatic Load Nonulcer Dyspepsia Psychosomatic Research 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Lipowski, Z. J. (1986). Psychosomatic medicine: Past and present. Part II. Current state. Canadian Journal of Psychiatry, 31, 8–13.Google Scholar
  2. 2.
    Fava, G. A., & Sonino, N. (2010). Psychosomatic medicine. International Journal of Clinical Practice, 64, 1155–1161.PubMedCrossRefGoogle Scholar
  3. 3.
    Wise, T. N. (2010). Psychosomatic medicine: An approach needed now more than ever. International Journal of Clinical Practice, 64, 999–1001.PubMedCrossRefGoogle Scholar
  4. 4.
    Fava, G. A., & Sonino, N. (2010). Psychosomatic medicine: A name to keep. Psychotherapy and Psychosomatics, 79, 1–3.PubMedCrossRefGoogle Scholar
  5. 5.
    Fava, G. A., Sonino, N., & Wise, T. N. (Eds.). (2012). The psychosomatic assessment. Strategies to improve clinical practice (Advances in psychosomatic medicine, Vol. 32). Basel, Switzerland: Karger.Google Scholar
  6. 6.
    Kroenke, K. (2002). Psychological medicine. BMJ, 324, 1536–1537.PubMedCrossRefGoogle Scholar
  7. 7.
    Novack, D. H., Cameron, O., Epel, E., et al. (2007). Psychosomatic medicine: The scientific foundation of the biopsychosocial model. Academic Psychiatry, 31, 388–401.PubMedCrossRefGoogle Scholar
  8. 8.
    McEwen, B. S. (2007). Physiology and neurobiology of stress and adaptation: Central role of the brain. Physiological Reviews, 87, 873–904.PubMedCrossRefGoogle Scholar
  9. 9.
    Fava, G. A., Guidi, J., Semprini, F., et al. (2010). Clinical assessment of allostatic load and clinimetric criteria. Psychotherapy and Psychosomatics, 79, 280–284.PubMedCrossRefGoogle Scholar
  10. 10.
    McCauley, J., Kern, D. E., Kolodner, K., et al. (1997). Clinical characteristics of women with a history of childhood abuse. JAMA: The Journal of the American Medical Association, 277, 1362–1368.CrossRefGoogle Scholar
  11. 11.
    Romans, S., & Cohen, M. (2008). Unexplained and underpowered: The relationship between psychosomatic disorders and interpersonal abuse. Harvard Review of Psychiatry, 16, 35–44.PubMedCrossRefGoogle Scholar
  12. 12.
    McEwen, B. S., & Stellar, E. (1993). Stress and the individual. Mechanisms leading to disease. Archives of Internal Medicine, 153, 2093–2101.PubMedCrossRefGoogle Scholar
  13. 13.
    Rozanski, A., Blumenthal, J. A., & Kaplan, J. (1999). Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation, 99, 2192–2217.PubMedCrossRefGoogle Scholar
  14. 14.
    Sonino, N., Tomba, E., & Fava, G. A. (2007). Psychosocial approach to endocrine disease. Advances in Psychosomatic Medicine, 28, 21–33.PubMedCrossRefGoogle Scholar
  15. 15.
    Wright, R. J., Rodriguez, M., & Cohen, S. (1998). Review of psychosocial stress and asthma. Thorax, 53, 1066–1074.PubMedCrossRefGoogle Scholar
  16. 16.
    Picardi, A., & Abeni, D. (2001). Stressful life events and skin disease. Psychotherapy and Psychosomatics, 70, 118–136.PubMedCrossRefGoogle Scholar
  17. 17.
    Mokdad, A. H., Marks, J. S., Stroup, D. F., et al. (2004). Actual causes of death in the United States, 2000. JAMA: The Journal of the American Medical Association, 291, 1238–1245.CrossRefGoogle Scholar
  18. 18.
    World Health Organization. (1948). Constitution of the World Health Organization basic document. Geneva, Switzerland: Author.Google Scholar
  19. 19.
    Ryff, C. D., & Singer, B. (1996). Psychological well-being. Psychotherapy and Psychosomatics, 65, 14–23.PubMedCrossRefGoogle Scholar
  20. 20.
    Caprara, G. V., Alessandri, G., & Barbaranelli, C. (2010). Optimal functioning. Psychotherapy and Psychosomatics, 79, 328–330.PubMedCrossRefGoogle Scholar
  21. 21.
    Pressman, S. D., & Cohen, S. (2005). Does positive affect influence health? Psychological Bulletin, 131, 925–971.PubMedCrossRefGoogle Scholar
  22. 22.
    Chida, Y., & Steptoe, A. (2008). Positive psychological well-being and mortality. Psychosomatic Medicine, 70, 741–756.PubMedCrossRefGoogle Scholar
  23. 23.
    Shah, S. U., White, A., White, S., et al. (2004). Heart and mind: (1) Relationship between cardiovascular and psychiatric conditions. Postgraduate Medical Journal, 80, 683–689.PubMedCrossRefGoogle Scholar
  24. 24.
    Taylor, G. J. (2010). Affects, trauma, and mechanisms of symptom formation. A tribute to John C. Nemiah, MD (1918–2009). Psychotherapy and Psychosomatics, 79, 339–349.PubMedCrossRefGoogle Scholar
  25. 25.
    Prince, M., Patel, V., Saxena, S., et al. (2007). No health without mental health. Lancet, 370, 859–877.PubMedCrossRefGoogle Scholar
  26. 26.
    Pohle, K., Domscheke, K., Roehrs, T., et al. (2009). Medical comorbidity affects antidepressant treatment response in patients with melancholic depression. Psychotherapy and Psychosomatics, 78, 359–363.PubMedCrossRefGoogle Scholar
  27. 27.
    Sonino, N., Fava, G. A., & Fallo, F. (2010). Psychosomatic aspects of Cushing’s syndrome. Reviews in Endocrine & Metabolic Disorders, 11, 95–104.CrossRefGoogle Scholar
  28. 28.
    Aj, M., Vaze, A., & Rao, S. (2009). Clinical diagnosis of depression in primary care: A meta-analysis. Lancet, 374, 609–619.CrossRefGoogle Scholar
  29. 29.
    Mitchell, A. J., Rao, S., & Vaze, A. (2010). Do primary care physicians have particular difficulty identifying late-life depression? A meta-analysis stratified by age. Psychotherapy and Psychosomatics, 79, 285–294.PubMedCrossRefGoogle Scholar
  30. 30.
    Katon, W. J. (2003). Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biological Psychiatry, 54, 216–226.PubMedCrossRefGoogle Scholar
  31. 31.
    Schulz, R., Drayer, R. A., & Rollman, B. L. (2002). Depression as a risk factor for non-suicide mortality in the elderly. Biological Psychiatry, 52, 205–225.PubMedCrossRefGoogle Scholar
  32. 32.
    di Matteo, M. R., Lepper, H. S., & Croghan, T. W. (2000). Depression is a risk factor for noncompliance with medical treatment. Archives of Internal Medicine, 160, 2101–2107.CrossRefGoogle Scholar
  33. 33.
    Frasure-Smith, N., & Lesperance, F. (2003). Depression and other psychological risks following myocardial infarction. Archives of General Psychiatry, 60, 627–636.PubMedCrossRefGoogle Scholar
  34. 34.
    Lemogne, C., Nabi, H., Zins, M., et al. (2010). Hostility may explain the association between depressive mood and mortality: Evidence from the French GAZEL cohort study. Psychotherapy and Psychosomatics, 79, 164–171.PubMedCrossRefGoogle Scholar
  35. 35.
    Dirmaier, J., Watzke, B., Koch, U., et al. (2010). Diabetes in primary care: Prospective associations between depression, nonadherence and glycemic control. Psychotherapy and Psychosomatics, 79, 172–178.PubMedCrossRefGoogle Scholar
  36. 36.
    Kojima, M., Hayano, J., Suzuki, S., et al. (2010). Depression, alexithymia and long-term mortality in chronic hemodialysis patients. Psychotherapy and Psychosomatics, 79, 303–311.PubMedCrossRefGoogle Scholar
  37. 37.
    Roy-Byrne, P. P., Davidson, K. W., Kessler, R. C., et al. (2008). Anxiety disorders and comorbid medical illness. General Hospital Psychiatry, 30, 208–225.PubMedCrossRefGoogle Scholar
  38. 38.
    Fava, G. A., Porcelli, P., Rafanelli, C., et al. (2010). The spectrum of anxiety disorders in the medically ill. The Journal of Clinical Psychiatry, 71, 910–914.PubMedCrossRefGoogle Scholar
  39. 39.
    Beutel, M. E., Bleichner, F., von Heymann, F., et al. (2010). Anxiety disorders and comorbidity in psychosomatic inpatients. Psychotherapy and Psychosomatics, 79, 58.PubMedCrossRefGoogle Scholar
  40. 40.
    Fava, G. A., Fabbri, S., Sirri, L., et al. (2007). Psychological factors affecting medical condition: A new proposal for DSM-V. Psychosomatics, 48, 103–111.PubMedCrossRefGoogle Scholar
  41. 41.
    Porcelli, P., & Sonino, N. (Eds.). (2007). Psychological factors affecting medical conditions. A new classification for DSM-V. Basel, Switzerland: Karger.Google Scholar
  42. 42.
    Wise, T. N. (2009). Diagnostic criteria for psychosomatic research are necessary for DSM-V. Psychotherapyand Psychosomatics, 78, 330–332.PubMedCrossRefGoogle Scholar
  43. 43.
    Porcelli, P., Bellomo, A., Quartesan, R., et al. (2009). Psychosocial functioning in consultation-liaison psychiatry patients. Psychotherapy and Psychosomatics, 78, 352–358.PubMedCrossRefGoogle Scholar
  44. 44.
    Fava, G. A., & Wise, T. N. (2007). Psychological factors affecting either identified or feared medical conditions: A solution for somatoform disorders. The American Journal of Psychiatry, 164, 1002–1003.PubMedCrossRefGoogle Scholar
  45. 45.
    Kellner, R. (1994). Psychosomatic syndromes, somatization and somatoform disorders. Psychotherapy and Psychosomatics, 61, 4–24.PubMedCrossRefGoogle Scholar
  46. 46.
    Engel, G. L. (1970). Conversion symptoms. In C. M. Mac Bryde & R. S. Blacklow (Eds.), Signs and symptoms (pp. 650–699). Philadelphia: Lippincott.Google Scholar
  47. 47.
    Goldbeck, R. (1997). Denial in physical illness. Journal of Psychosomatic Research, 43, 575–593.PubMedCrossRefGoogle Scholar
  48. 48.
    Cockram, C. A., Doros, G., & de Figueiredo, J. M. (2009). Diagnosis and measurement of subjective incompetence: The clinical hallmark of demoralization. Psychotherapy and Psychosomatics, 78, 342–345.PubMedCrossRefGoogle Scholar
  49. 49.
    Mangelli, L., Fava, G. A., Grandi, S., et al. (2005). Assessing demoralization and depression in the setting of medical disease. The Journal of Clinical Psychiatry, 66, 391–394.PubMedCrossRefGoogle Scholar
  50. 50.
    Sirri, L., Fava, G. A., & Wise, T. N. (2011). Psychiatric classification in the setting of medical disease: Comparing the clinical value of different proposals. Journal of Psychosomatic Research, 70, 493–495.PubMedCrossRefGoogle Scholar
  51. 51.
    Mangelli, L., Fava, G. A., Grassi, L., et al. (2006). Irritable mood in Italian patients with medical disease. The Journal of Nervous and Mental Disease, 194, 226–228.PubMedCrossRefGoogle Scholar
  52. 52.
    Härter, M., Baumeister, H., Reuter, K., et al. (2007). Increased 12-month prevalence rates of mental disorders in patients with chronic somatic diseases. Psychotherapy and Psychosomatics, 76, 354–360.PubMedCrossRefGoogle Scholar
  53. 53.
    Tinetti, M. E., & Fried, T. (2004). The end of the disease era. American Journal of Medicine, 116, 179–185.PubMedCrossRefGoogle Scholar
  54. 54.
    Engel, G. L. (1977). The need for a new medical model: A challenge for biomedicine. Science, 196, 129–136.PubMedCrossRefGoogle Scholar
  55. 55.
    Fava, G. A., & Sonino, N. (2009). Psychosomatic assessment. Psychotherapy and Psychosomatics, 78, 333–341.PubMedCrossRefGoogle Scholar
  56. 56.
    Sonino, N., & Peruzzi, P. (2009). A psychoneuroendocrinology service. Psychotherapy and Psychosomatics, 78, 346–351.PubMedCrossRefGoogle Scholar
  57. 57.
    Lipowski, Z. J. (1974). Physical illness and psychopathology. International Journal of Psychiatry in Medicine, 5, 483–497.PubMedCrossRefGoogle Scholar
  58. 58.
    Feinstein, A. R. (1982). The Jones criteria and the challenge of clinimetrics. Circulation, 66, 1–5.PubMedCrossRefGoogle Scholar
  59. 59.
    Feinstein, A. R. (1987). Clinimetrics. New Haven, CT: Yale University Press.Google Scholar
  60. 60.
    Fava, G. A., Tomba, E., & Sonino, N. (2012). Clinimetrics: The science of clinical measurements. International Journal of Clinical Practice, 66, 11–15.PubMedCrossRefGoogle Scholar
  61. 61.
    Fava, G. A., Rafanelli, C., & Tomba, E. (2012). The clinical process in psychiatry: A clinimetric approach. The Journal of Clinical Psychiatry, 73, 177–184.PubMedCrossRefGoogle Scholar
  62. 62.
    Feinstein, A. R. (1970). The pre-therapeutic classification of comorbidity in chronic disease. Journal of Chronic Diseases, 23, 455–468.CrossRefGoogle Scholar
  63. 63.
    deGroot, V., Beckerman, H., Lankhorst, G. J., et al. (2003). How to measure comorbidity: A critical review of available methods. Journal of Clinical Epidemiology, 56, 221–229.CrossRefGoogle Scholar
  64. 64.
    Emmelkamp, P. M. G., Bouman, T. K., & Scholing, A. (1993). Anxiety disorders (pp. 55–67). Chichester, England: Wiley.Google Scholar
  65. 65.
    Emmelkamp, P. M. G. (2004). The additional value of clinimetrics needs to be established rather than assumed. Psychotherapy and Psychosomatics, 73, 142–144.PubMedCrossRefGoogle Scholar
  66. 66.
    Joosten, E. A. G., De Fuentes-Merillas, L., de Weert, G. H., et al. (2008). Systematic review of the effects of shared-decision making on patient satisfaction, treatment adherence and health status. Psychotherapy and Psychosomatics, 77, 219–226.PubMedCrossRefGoogle Scholar
  67. 67.
    Joosten, E. A. G., de Jong, C. A. J., de Weert-van Oene, G. H., et al. (2009). Shared decision making reduces drug use and psychiatry severity in substance-dependent patients. Psychotherapy and Psychosomatics, 78, 245–253.PubMedCrossRefGoogle Scholar
  68. 68.
    Fava, G. A., & Kellner, R. (1993). Staging: A neglected dimension in psychiatric classification. Acta Psychiatrica Scandinavica, 87, 225–230.PubMedCrossRefGoogle Scholar
  69. 69.
    Feinstein, A. R. (1973). An analysis of diagnostic reasoning. I The domains and disorders of clinical macrobiology. The Yale Journal of Biology and Medicine, 46, 212–232.PubMedGoogle Scholar
  70. 70.
    Engel, G. L. (1967). The concept of psychosomatic disorder. Journal of Psychosomatic Research, 11, 3–9.PubMedCrossRefGoogle Scholar
  71. 71.
    Aaron, L. A., & Buchwald, D. (2001). A review of the evidence for overlap among unexplained clinical conditions. Annals of Internal Medicine, 134, 868–881.PubMedCrossRefGoogle Scholar
  72. 72.
    Fava, G. A., Tomba, E., & Grandi, S. (2007). The road to recovery from depression. Psychotherapy and Psychosomatics, 76, 260–265.PubMedCrossRefGoogle Scholar
  73. 73.
    Fava, G. A., Grandi, S., Rafanelli, C., et al. (2000). Explanatory therapy of hypochondriasis. The Journal of Clinical Psychiatry, 61, 317–322.PubMedCrossRefGoogle Scholar
  74. 74.
    Fava, G. A., & Tomba, E. (2009). Increasing psychological well-being and resilience by psychotherapeutic methods. Journal of Personality, 77, 1903–1934.PubMedCrossRefGoogle Scholar
  75. 75.
    Feinstein, A. R. (1973). An analysis of diagnostic reasoning. II. The strategy of intermediate decisions. The Yale Journal of Biology and Medicine, 46, 264–283.PubMedGoogle Scholar
  76. 76.
    Feinstein, A. R. (1999). Basic biomedical science and the destruction of the pathophysiological bridge from bench to bedside. American Journal of Medicine, 107, 461–467.PubMedCrossRefGoogle Scholar
  77. 77.
    Dantzer, R. (2005). Somatization: A psychoneuroimmune perspective. Psychoneuroendocri-nology, 30, 947–952.PubMedCrossRefGoogle Scholar
  78. 78.
    Price, D. D., Finniss, D. G., & Benedetti, F. (2008). A comprehensive review of the placebo effect. Annual Review of Psychology, 59, 565–590.PubMedCrossRefGoogle Scholar
  79. 79.
    Walach, H., Bosch, H., Lewith, G., et al. (2008). Effectiveness of distant healing for patients with chronic fatigue syndrome. Psychotherapy and Psychosomatics, 77, 158–166.PubMedCrossRefGoogle Scholar
  80. 80.
    Thayer, J. F., & Brosschot, J. F. (2005). Psychosomatics and psychopathology. Psychoneuroendocrinology, 30, 1050–1058.PubMedCrossRefGoogle Scholar
  81. 81.
    Tak, L. M., Janssens, K. A., Dietrich, A., et al. (2010). Age-specific associations between cardiac vagal activity and functional somatic symptoms: A population-based study. Psychotherapy and Psychosomatics, 79, 179–187.PubMedCrossRefGoogle Scholar
  82. 82.
    Zachariae, R., Paulsen, K., Mehlsen, M., et al. (2007). Chemotherapy-induced nausea, vomiting and fatigue. Psychotherapy and Psychosomatics, 76, 376–384.PubMedCrossRefGoogle Scholar
  83. 83.
    Bech, P. (2009). Fifty years with the Hamilton Scales for anxiety and depression. Psychotherapy and Psychosomatics, 78, 202–211.PubMedCrossRefGoogle Scholar
  84. 84.
    Carroll, B. J. (1994). Brain mechanisms in manic depression. Clinical Chemistry, 40, 303–308.PubMedGoogle Scholar
  85. 85.
    Fava, G. A. (1987). Irritable mood and physical illness. Stress Medicine, 3, 293–299.CrossRefGoogle Scholar
  86. 86.
    Kamarck, T. W., Haskett, R. F., Muldoon, M., et al. (2009). Citalopram intervention for hostility. Journal of Consulting and Clinical Psychology, 77, 174–188.PubMedCrossRefGoogle Scholar
  87. 87.
    Charney, D. S. (2004). Psychobiological mechanisms of resilience and vulnerability. The American Journal of Psychiatry, 161, 195–216.PubMedCrossRefGoogle Scholar
  88. 88.
    Cloninger, C. R. (1987). Systematic method for clinical description and classification of personality. Archives of General Psychiatry, 44, 573–588.PubMedCrossRefGoogle Scholar
  89. 89.
    Fava, M., Littman, A., & Halperin, P. (1987). Neuroendocrine correlates of the type A behavior pattern. International Journal of Psychiatry in Medicine, 17, 289–307.PubMedCrossRefGoogle Scholar
  90. 90.
    Rapp, M. A., Rieckmann, N., Lessman, D. A., et al. (2010). Persistent depressive symptoms after acute coronary syndrome are associated with compromised white matter integrity in the anterior cingulate: A pilot study. Psychotherapy and Psychosomatics, 79, 149–155.PubMedCrossRefGoogle Scholar
  91. 91.
    Lichtenberg, P., & Belmaker, R. H. (2010). Subtyping major depressive disorder. Psychotherapy and Psychosomatics, 79, 131–135.PubMedCrossRefGoogle Scholar
  92. 92.
    Bech, P. (2010). The struggle for subtypes in primary and secondary depression and their mode-specific treatment or healing. Psychotherapy and Psychosomatics, 79, 331–338.PubMedCrossRefGoogle Scholar
  93. 93.
    Baumeister, H., & Parker, G. (2010). A second thought on subtyping major depression. Psychotherapy and Psychosomatics, 79, 388–389.PubMedCrossRefGoogle Scholar
  94. 94.
    Guidi, J., Fava, G. A., Picardi, A., et al. (2011). Subtyping depression in the medically ill by cluster analysis. Journal of Affective Disorders, 132, 383–388.PubMedCrossRefGoogle Scholar
  95. 95.
    Fava, G. A., Guidi, J., Porcelli, P., et al. (2012). A cluster analysis-derived classification of psychological distress and illness behavior in the medically ill. Psychological Medicine, 42, 401–407.CrossRefGoogle Scholar
  96. 96.
    Tomba, E. (2012). Assessment of lifestyle in relation to health. Advances in Psychosomatic Medicine, 32, 72–96.PubMedCrossRefGoogle Scholar
  97. 97.
    Narayan, K. M. V., Kanaya, A. M., & Gregg, E. W. (2003). Lifestyle intervention for the prevention of type 2 diabetes mellitus. Treatments in Endocrinology, 2, 315–320.PubMedCrossRefGoogle Scholar
  98. 98.
    Compas, B. E., Haagon, D. A., Keefe, F. J., et al. (1998). Sampling of empirically supported psychological treatments from health psychology: Smoking, chronic pain, cancer, and bulimia nervosa. Journal of Consulting and Clinical Psychology, 66, 89–112.PubMedCrossRefGoogle Scholar
  99. 99.
    Bodenheimer, T., Lorig, K., Holman, H., et al. (2002). Patient self-management of chronic disease in primary care. JAMA: The Journal of the American Medical Association, 288, 2469–2475.CrossRefGoogle Scholar
  100. 100.
    Jackson, J. L., de Zee, K., & Berbano, E. (2004). Can treating depression improve disease outcomes? Annals of Internal Medicine, 140, 1054–1056.PubMedCrossRefGoogle Scholar
  101. 101.
    Pigott, H. E., Leventhal, A. M., Alter, G. S., et al. (2010). Efficacy and effectiveness of antidepressants. Psychotherapy and Psychosomatics, 79, 267–279.PubMedCrossRefGoogle Scholar
  102. 102.
    Balon, R. (2009). Cognitive-behavioral therapy, psychotherapy and psychosocial interventions in the medically ill. Psychotherapy and Psychosomatics, 78, 261–264.PubMedCrossRefGoogle Scholar
  103. 103.
    Kaupp, J. W., Rapaport-Hubschman, N., & Spiegel, D. (2005). Psychosocial treatments. In J. L. Levenson (Ed.), Textbook of psychosomatic medicine (pp. 923–956). Washington, DC: American Psychiatric Press.Google Scholar
  104. 104.
    Abbass, A., Kisely, S., & Kroenke, K. (2009). Short-term psychodynamic psychotherapy for somatic disorders. Psychotherapy and Psychosomatics, 78, 265–274.PubMedCrossRefGoogle Scholar
  105. 105.
    Andersen, B. L., Yang, H. C., Farrar, W. B., et al. (2008). Psychologic intervention improves survival for breast cancer patients. Cancer, 113, 3450–3458.PubMedCrossRefGoogle Scholar
  106. 106.
    Herschbach, P., Berg, P., Waadt, S., et al. (2010). Group psychotherapy of dysfunctional fear of progression in patients with chronic arthritis or cancer. Psychotherapy and Psychosomatics, 79, 31–38.PubMedCrossRefGoogle Scholar
  107. 107.
    Grassi, L., Sabato, S., Rossi, E., et al. (2010). Effects of supportive-expressive group therapy in breast cancer patients with affective disorders: A pilot study. Psychotherapy and Psychosomatics, 79, 39–47.PubMedCrossRefGoogle Scholar
  108. 108.
    Tulipani, C., Morelli, F., Spedicato, M. R., et al. (2010). Alexithymia and cancer pain: The effect of psychological intervention. Psychotherapy and Psychosomatics, 79, 156–163.PubMedCrossRefGoogle Scholar
  109. 109.
    Turk, D. C., Swanson, K. S., & Tunks, E. R. (2008). Psychological approaches in the treatment of chronic pain patients. Canadian Journal of Psychiatry, 53, 213–223.Google Scholar
  110. 110.
    Lahmann, C., Nickel, M., Schuster, T., et al. (2009). Functional relaxation and guided imagery as complementary therapy in asthma: A randomized controlled clinical trial. Psychotherapy and Psychosomatics, 78, 233–239.PubMedCrossRefGoogle Scholar
  111. 111.
    Frisina, P. G., Borod, J. C., & Lepore, S. J. (2004). A meta-analysis of the effects of written emotional disclosure on the health outcomes of clinical populations. The Journal of Nervous and Mental Disease, 192, 629–634.PubMedCrossRefGoogle Scholar
  112. 112.
    van Middendorp, H., Geenen, R., Sorbi, M. J., et al. (2009). Health and physiological effects of an emotional disclosure intervention adapted for application at home: A randomized clinical trial in rheumatoid arthritis. Psychotherapy and Psychosomatics, 78, 145–151.PubMedCrossRefGoogle Scholar
  113. 113.
    Sirri, L., Grandi, S., & Fava, G. A. (2008). The illness attitude scales. Psychotherapy and Psychosomatics, 77, 337–350.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of PsychologyUniversity of BolognaBolognaItaly
  2. 2.Laboratory of Psychosomatics and Clinimetrics, Department of PsychologyUniversity of BolognaBolognaItaly
  3. 3.Department of PsychiatryState University of New York at BuffaloBuffaloUSA

Personalised recommendations